1. 184ODistant disease-free survival (DDFS) according to response category in neoadjuvant endocrine therapy (NET): 6-year analysis in phase III NEOS trial. (23rd October 2018) Authors: Iwata, H; Masuda, N; Yamamoto, Y; Fujisawa, T; Toyama, T; Taira, N; Kashiwaba, M; Ohtani, S; Sakai, T; Hasegawa, Y; Nakamura, R; Akabane, H; Shibahara, Y; Sasano, H; Yamaguchi, T; Ohashi, Y Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗